ID24530A - Turunan-turunan makrolidan yang tersubstitusi c-4 - Google Patents

Turunan-turunan makrolidan yang tersubstitusi c-4

Info

Publication number
ID24530A
ID24530A IDW991565A ID991565A ID24530A ID 24530 A ID24530 A ID 24530A ID W991565 A IDW991565 A ID W991565A ID 991565 A ID991565 A ID 991565A ID 24530 A ID24530 A ID 24530A
Authority
ID
Indonesia
Prior art keywords
macrolidant
deposits
substituted
macrolidant deposits
Prior art date
Application number
IDW991565A
Other languages
English (en)
Indonesian (id)
Inventor
Brian Scott
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24530A publication Critical patent/ID24530A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW991565A 1997-06-11 1998-05-25 Turunan-turunan makrolidan yang tersubstitusi c-4 ID24530A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4998097P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
ID24530A true ID24530A (id) 2000-07-20

Family

ID=21962765

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991565A ID24530A (id) 1997-06-11 1998-05-25 Turunan-turunan makrolidan yang tersubstitusi c-4

Country Status (39)

Country Link
EP (1) EP0988309B1 (fr)
JP (1) JP3262806B2 (fr)
KR (1) KR100369959B1 (fr)
CN (1) CN1145636C (fr)
AP (1) AP1189A (fr)
AR (1) AR013085A1 (fr)
AT (1) ATE310742T1 (fr)
AU (1) AU745006C (fr)
BG (1) BG64357B1 (fr)
BR (1) BR9810097A (fr)
CA (1) CA2293397C (fr)
CO (1) CO4950584A1 (fr)
DE (1) DE69832486T2 (fr)
DZ (1) DZ2515A1 (fr)
EA (1) EA002440B1 (fr)
ES (1) ES2251081T3 (fr)
GT (1) GT199800075A (fr)
HN (1) HN1998000074A (fr)
HR (1) HRP980315A2 (fr)
HU (1) HUP0004076A3 (fr)
ID (1) ID24530A (fr)
IL (1) IL132808A (fr)
IS (1) IS1979B (fr)
MA (1) MA24563A1 (fr)
MY (1) MY133027A (fr)
NO (1) NO315560B1 (fr)
NZ (1) NZ500652A (fr)
OA (1) OA11226A (fr)
PA (1) PA8452001A1 (fr)
PE (1) PE79999A1 (fr)
PL (1) PL337497A1 (fr)
SK (1) SK168299A3 (fr)
TN (1) TNSN98084A1 (fr)
TW (2) TW200418871A (fr)
UA (1) UA70298A (fr)
UY (1) UY25041A1 (fr)
WO (1) WO1998056801A1 (fr)
YU (1) YU62999A (fr)
ZA (1) ZA985016B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE353014T1 (de) * 1997-09-10 2007-02-15 Merial Ltd Verwendung von 9a-azaliden als antimikrobielle mittel für tiere
EP1779853A3 (fr) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides en tant qu'agents anti-microbiens à usage vétérinaire
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
EP1437360A3 (fr) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11-carbamates des macrolides antibactériens
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
TR200200436T2 (tr) 1998-11-03 2002-06-21 Pfizer Inc. Yeni makrolit antibiyotikler
CA2292359C (fr) * 1999-01-28 2004-09-28 Pfizer Products Inc. Nouveaux azalides et procede de fabrication
ATE315042T1 (de) * 1999-08-24 2006-02-15 Abbott Lab 9a-azalide mit antibakterieller wirkung
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
BRPI0017013B1 (pt) 2000-01-27 2015-07-14 Zoetis P Llc Composição de antibiótico azalídeo e método para sua obtenção
WO2002088158A1 (fr) * 2001-04-27 2002-11-07 Pfizer Products Inc. Procede de preparation de derives de 9-deoxo-9a-aza-9a-homoerythromycine a substitues en 4''
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2003255851B2 (en) 2002-07-08 2009-07-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
EP1551865B1 (fr) 2002-07-08 2009-04-22 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Molecules hybrides de macrolides avec des molecules anti-inflammatoires steroidiennes/non-steroidiennes
NZ537716A (en) * 2002-07-08 2007-05-31 Glaxosmithkline Zagreb Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
EP1638549A4 (fr) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc Nouveaux agents antibacteriens
WO2005030227A1 (fr) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. Derives 9a-azalide 11-3c-bicycliques
EP2716647A3 (fr) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Composes Macrocycliques Et Leurs Procedes De Fabrication Et D'utilisation
WO2009019868A1 (fr) 2007-08-06 2009-02-12 Taisho Pharmaceutical Co., Ltd. Composé 10a-azalide réticulé en position 10a et en position 12
CA2703475A1 (fr) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Procede pour la preparation d'agents antibacteriens macrolides
WO2009139181A1 (fr) 2008-05-15 2009-11-19 大正製薬株式会社 Composé 10a-azalide ayant une structure de cycle à 4 chaînons
US8796232B2 (en) 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2532455T3 (es) * 2010-09-20 2015-03-27 Novartis Tiergesundheit Ag Nuevo procedimiento de preparación de 9-desoxo-9a-aza-9a-homoeritromicina modificada en el C-4'' del anillo de cladinosa por un grupo epóxido
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
US10633407B2 (en) 2014-10-08 2020-04-28 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
EP3273969A4 (fr) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides à sucres modifiés de type désosamine et utilisations de ceux-ci
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
EP4118092B1 (fr) * 2020-03-12 2025-07-16 Zoetis Services LLC Azalides immunomodulateurs o-het-aryle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ATE38519T1 (de) * 1983-09-06 1988-11-15 Pfizer Azahomoerythromycin-b-derivate und zwischenprodukte.
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (fr) * 1991-04-04 1998-08-04 James V. Heck Derives de 9-desoxo-8a-aza-8a-homoerythromycine a modifies en positions 4"- et 8a
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5412982A (en) * 1994-03-10 1995-05-09 Potts; James K. Windsock support

Also Published As

Publication number Publication date
MA24563A1 (fr) 1998-12-31
DZ2515A1 (fr) 2003-02-01
BG64357B1 (bg) 2004-11-30
ES2251081T3 (es) 2006-04-16
NO996107L (no) 2000-02-10
MY133027A (en) 2007-10-31
TWI224106B (en) 2004-11-21
NO315560B1 (no) 2003-09-22
CN1259955A (zh) 2000-07-12
OA11226A (en) 2003-07-16
EP0988309B1 (fr) 2005-11-23
AR013085A1 (es) 2000-12-13
DE69832486D1 (de) 2005-12-29
CA2293397C (fr) 2004-08-31
BR9810097A (pt) 2000-08-08
SK168299A3 (en) 2000-09-12
AP1189A (en) 2003-07-16
KR100369959B1 (ko) 2003-02-12
UA70298C2 (uk) 2004-10-15
AU7228198A (en) 1998-12-30
EA002440B1 (ru) 2002-04-25
UY25041A1 (es) 2000-09-29
EA199901014A1 (ru) 2000-06-26
PE79999A1 (es) 1999-08-25
CO4950584A1 (es) 2000-09-01
YU62999A (sh) 2002-10-18
WO1998056801A1 (fr) 1998-12-17
AP9801254A0 (en) 1998-06-30
EP0988309A1 (fr) 2000-03-29
PA8452001A1 (es) 2000-05-24
HUP0004076A2 (hu) 2001-04-28
HN1998000074A (es) 1999-01-08
CA2293397A1 (fr) 1998-12-17
NO996107D0 (no) 1999-12-10
UA70298A (uk) 2004-10-15
IL132808A0 (en) 2001-03-19
TW200418871A (en) 2004-10-01
KR20010013633A (ko) 2001-02-26
HUP0004076A3 (en) 2003-05-28
CN1145636C (zh) 2004-04-14
AU745006B2 (en) 2002-03-07
DE69832486T2 (de) 2006-07-27
ATE310742T1 (de) 2005-12-15
GT199800075A (es) 1999-11-30
ZA985016B (en) 1999-12-10
IL132808A (en) 2004-08-31
HRP980315A2 (en) 1999-04-30
IS5250A (is) 1999-11-16
NZ500652A (en) 2001-10-26
JP3262806B2 (ja) 2002-03-04
TNSN98084A1 (fr) 2005-03-15
HK1025974A1 (en) 2000-12-01
BG103969A (en) 2000-07-31
PL337497A1 (en) 2000-08-28
JP2000514097A (ja) 2000-10-24
IS1979B (is) 2005-01-14
AU745006C (en) 2006-02-23

Similar Documents

Publication Publication Date Title
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
ID17140A (id) Ritsleting yang dicetak
ID27884A (id) Asam-asam indolealkanoat yang disubstitusikan.
ID20976A (id) Popok sekali pakai
ID21018A (id) Popok sekali pakai
ID26308A (id) Dihidropirimidin baru yang tersubstitusi secara 2-heterosiklik
ID20043A (id) Popok sekali pakai
ID21602A (id) Popok sekali pakai
ID20975A (id) Popok sekali pakai
ID26334A (id) Morfolinol yang aktif secara farmasi
DE69831821D1 (de) Hochleitungs-zweischichtigesreibungsmaterial
ATE250583T1 (de) Substituierte 3-cyanochinoline
ID21197A (id) Popok sekali pakai
DE59905479D1 (de) FeRAM-ANORDNUNG
FR2771009B1 (fr) Biostimulant
ID16298A (id) Turunan-turunan 1,2,3,4-tetrahidronaftalena yang disubstitusi
DE59813670D1 (de) Bohrhammer
ID21770A (id) Plester yang mengandung felbinak
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
PT1084251E (pt) Pestivirus atenuados
MA24648A1 (fr) Electrolyseur
NO20010154L (no) Brønnhulls-strekksvivelovergang
ID23429A (id) Komposisi-komposisi sertralina yang larut
ID23696A (id) Turunan siklobutilamina tersubstitusi
DE59708076D1 (de) Türschloss